CLINICAL_TRIALS
trial_result
· 2015-02-11
Clinical Trial Update: Safety and Immunogenicity Study of Recombinant Ricin Toxin A-Chain Vaccine (RVEc™) [Phase 1]
Summary
Phase 1 trial evaluating safety and immunogenicity of the recombinant ricin toxin A-chain vaccine (RVEc).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: U.S. Army Medical Research and Development Command | Conditions: Ricin | Phase 1 | Status: COMPLETED | Results posted: 2015-02-11